Axitan CEO discusses endolysins and the dramatic early life impact of FORC3 with The Poultry Site

Sarah Mikesell, The Poultry Site Editor’s Note: As previously reported, Axitan has developed a ground breaking approach for addressing economically important bacteria that impact the livestock industry by using naturally occurring antimicrobial enzymes, known as endolysins. I thought it would be timely to check in with their new CEO, Al Zimmerman, to see how things are progressing with their first product, FORC3®, which has been developed to target Clostridium perfringens, the bacteria that causes necrotic enteritis in poultry.

The article can be found here

Previous
Previous

AXITAN APPOINTS EX NOVUS MD AS ITS VP SALES & MARKETING

Next
Next

Axitan CEO discusses endolysins and the dramatic early life impact of FORC3 with The Poultry Site